Predicting Individual Radiation Sensitivity: Current and Evolving Technologiesстатья из журнала
Аннотация: In 2005, the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health established a Radiation/Nuclear Program to develop radioprotectors, mitigators and therapeutic agents to facilitate an effective medical response against radiological and nuclear threats. This program also supports development of biomarker/biodosimetry techniques and devices for rapid triage and treatment of radiation exposed individuals after any radiological event. In support of this program, NIAID in collaboration with the Columbia University Medical Center organized a workshop entitled Predicting Individual Radiation Sensitivity: Current and Evolving Technologies. The meeting was held at Columbia University in New York on March 17-18, 2008, and was attended by 86 participants from eight countries. The background to the Workshop relates to the need for mass biodosimetry and mitigation/therapy after a large-scale radiological event, both in regard to short-term sequelae and also in terms of long-term end points such as carcinogenesis and heart disease. While retrospective dose estimates provide information about average risks, it is known from studies of higher-dose radiotherapy that there is considerable person-to-person variability in response to a given radiation dose. Thus the goals of this Workshop were to assess the significance of interindividual radiation sensitivity in terms of the aftermath of a large-scale radiological event and to assess whether the approaches used at clinical doses can be translated to lower doses or whether different approaches will be needed. Session themes were:
Год издания: 2008
Авторы: Narayani Ramakrishnana, David Brennerb
Издательство: Radiation Research Society
Источник: Radiation Research
Ключевые слова: Effects of Radiation Exposure, Radiation Therapy and Dosimetry, Radiation Dose and Imaging
Открытый доступ: closed
Том: 170
Выпуск: 5
Страницы: 666–675